These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 26912058)
1. Mesotheliomas show higher hyaluronan positivity around tumor cells than metastatic pulmonary adenocarcinomas. Törrönen K; Soini Y; Pääkkö P; Parkkinen J; Sironen R; Rilla K Histol Histopathol; 2016 Oct; 31(10):1113-22. PubMed ID: 26912058 [TBL] [Abstract][Full Text] [Related]
2. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas. Tot T Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies. Abutaily AS; Addis BJ; Roche WR J Clin Pathol; 2002 Sep; 55(9):662-8. PubMed ID: 12194995 [TBL] [Abstract][Full Text] [Related]
4. TTF-1 and surfactant-B as co-adjuvants in the diagnosis of lung adenocarcinoma and pleural mesothelioma. Bakir K; Koçer NE; Deniz H; Güldür ME Ann Diagn Pathol; 2004 Dec; 8(6):337-41. PubMed ID: 15614737 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung. Hattori Y; Yoshida A; Yoshida M; Takahashi M; Tsuta K Pathol Int; 2015 Jun; 65(6):286-92. PubMed ID: 25727644 [TBL] [Abstract][Full Text] [Related]
6. Significance of immunocytochemical expression of E-cadherin, N-cadherin and CD44 in serous effusions using liquid-based cytology. Malle D; Valeri RM; Photiou C; Kaplanis K; Andreadis C; Tsavdaridis D; Destouni C Acta Cytol; 2005; 49(1):11-6. PubMed ID: 15717748 [TBL] [Abstract][Full Text] [Related]
7. High CD44 expression on human mesotheliomas mediates association with hyaluronan. Penno MB; Askin FB; Ma H; Carbone M; Vargas MP; Pass HI Cancer J Sci Am; 1995; 1(3):196-203. PubMed ID: 9166476 [TBL] [Abstract][Full Text] [Related]
8. A novel biotinylated probe specific for hyaluronate. Its diagnostic value in diffuse malignant mesothelioma. Azumi N; Underhill CB; Kagan E; Sheibani K Am J Surg Pathol; 1992 Feb; 16(2):116-21. PubMed ID: 1733346 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues. Han AC; Peralta-Soler A; Knudsen KA; Wheelock MJ; Johnson KR; Salazar H Hum Pathol; 1997 Jun; 28(6):641-5. PubMed ID: 9190996 [TBL] [Abstract][Full Text] [Related]
10. Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma. Ordóñez NG Hum Pathol; 1998 Feb; 29(2):166-9. PubMed ID: 9490276 [TBL] [Abstract][Full Text] [Related]
11. Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature. Ordóñez NG Am J Clin Pathol; 1998 Jan; 109(1):85-9. PubMed ID: 9426522 [TBL] [Abstract][Full Text] [Related]
13. HBME-1, MOC-31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma. Oates J; Edwards C Histopathology; 2000 Apr; 36(4):341-7. PubMed ID: 10759948 [TBL] [Abstract][Full Text] [Related]
14. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12. Lee I; Radosevich JA; Chejfec G; Ma YX; Warren WH; Rosen ST; Gould VE Am J Pathol; 1986 Jun; 123(3):497-507. PubMed ID: 3717302 [TBL] [Abstract][Full Text] [Related]
15. Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma. Shijubo N; Honda Y; Fujishima T; Takahashi H; Kodama T; Kuroki Y; Akino T; Abe S Eur Respir J; 1995 Mar; 8(3):403-6. PubMed ID: 7789485 [TBL] [Abstract][Full Text] [Related]
16. Expression of snail, twist, and Zeb1 in malignant mesothelioma. Merikallio H; Pääkkö P; Salmenkivi K; Kinnula V; Harju T; Soini Y APMIS; 2013 Jan; 121(1):1-10. PubMed ID: 23030626 [TBL] [Abstract][Full Text] [Related]
17. "Thick" cell membranes revealed by immunocytochemical staining: a clue to the diagnosis of mesothelioma. Leong AS; Parkinson R; Milios J Diagn Cytopathol; 1990; 6(1):9-13. PubMed ID: 2323301 [TBL] [Abstract][Full Text] [Related]
18. Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma. Ordóñez NG Am J Surg Pathol; 2000 Apr; 24(4):598-606. PubMed ID: 10757409 [TBL] [Abstract][Full Text] [Related]
19. Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma. Kai Y; Amatya VJ; Kushitani K; Kambara T; Suzuki R; Tsutani Y; Miyata Y; Okada M; Takeshima Y Histopathology; 2019 Mar; 74(4):545-554. PubMed ID: 30329165 [TBL] [Abstract][Full Text] [Related]
20. The diagnostic utility of D2-40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology. Hyun TS; Barnes M; Tabatabai ZL Acta Cytol; 2012; 56(5):527-32. PubMed ID: 23075894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]